InvestSMART

Emyria Limited (ASX: EMD) - Announcements

Current share price for EMD : $0.038 0.001 (2.56%)+

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$31 Emyria Company Update - Video Presentation 16 Jun 2026 9:42AM $0.041 $0.038 fallen by 7.32%
$31 Emyria Company Update Presentation 11 Jun 2026 9:10AM $0.040 $0.038 fallen by 5%
$31 Notification of cessation of securities - EMD 9 Jun 2026 8:17AM $0.043 $0.038 fallen by 11.63%
$31 Change of Director's Interest Notice x 2 29 May 2026 6:32PM $0.049 $0.038 fallen by 22.45%
$31 Notification regarding unquoted securities - EMD 29 May 2026 6:30PM $0.049 $0.038 fallen by 22.45%
$31 Application for quotation of securities - EMD 29 May 2026 6:24PM $0.049 $0.038 fallen by 22.45%
$31 TGA Update to Accelerate Empax Therapist Recruitment 28 May 2026 9:46AM $0.040 $0.038 fallen by 5%
$31 Emyria Activates First Victorian Empax Clinic 18 May 2026 9:10AM $0.039 $0.038 fallen by 2.56%
$31 March Quarter Investor Video Presentation 5 May 2026 8:34AM $0.048 $0.038 fallen by 20.83%
$31 Results of General Meeting 1 May 2026 12:43PM $0.051 $0.038 fallen by 25.49%
$31 Emyria Extends National Expansion into New South Wales 29 Apr 2026 8:52AM $0.050 $0.038 fallen by 24%
$31 March 2026 Quarterly Activities Report and Appendix 4C 28 Apr 2026 9:26AM $0.053 $0.038 fallen by 28.30%
$31 Ignite Investment Summit Singapore Presentation 21 Apr 2026 8:14AM $0.056 $0.038 fallen by 32.14%
$31 Emyria Launches Global Partnership Program 20 Apr 2026 9:25AM $0.048 $0.038 fallen by 20.83%
$31 EMD Commences NSW Workforce Recruitment To Support Expansion 2 Apr 2026 9:33AM $0.050 $0.038 fallen by 24%
$31 Letter to Shareholders - Notice of General Meeting 30 Mar 2026 4:16PM $0.050 $0.038 fallen by 24%
$31 Notice of Extraordinary General Meeting/Proxy Form 30 Mar 2026 4:10PM $0.050 $0.038 fallen by 24%
$31 Key Milestones Achieved for First Victorian Empax Clinic 24 Mar 2026 9:43AM $0.038 $0.038 fallen by 0%
$31 Emyria to Present at NWR Virtual Healthcare Conference 24 Mar 2026 9:31AM $0.038 $0.038 fallen by 0%
$31 Record Half-Year Performance and National Expansion 26 Feb 2026 6:28PM $0.052 $0.038 fallen by 26.92%
$31 Appendix 4D and Half Year End Financial Report 26 Feb 2026 6:05PM $0.052 $0.038 fallen by 26.92%
$31 Application for quotation of securities - EMD 16 Feb 2026 7:24PM $0.057 $0.038 fallen by 33.33%
$31 Medibank Expands Funding to Emyria's Victorian Clinic 16 Feb 2026 8:40AM $0.054 $0.038 fallen by 29.63%
$31 Emyria Expands Investor Access Into Europe 12 Feb 2026 11:46AM $0.057 $0.038 fallen by 32.74%
$31 Application for quotation of securities - EMD 6 Feb 2026 8:17PM $0.051 $0.038 fallen by 25.49%

1 - 25 of 545 results

Page 1 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.